Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
Abstract Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive symptoms of learning and memory deficits. Such cognitive impairments are attributed to brain atrophy resulting from progressive neuronal and synaptic loss; therefore, alleviation of neural cell death is...
Main Authors: | Seung‐Hoon Yang, Dongkeun Kenneth Lee, Jisu Shin, Sejin Lee, Seungyeop Baek, Jiyoon Kim, Hoyong Jung, Jung‐Mi Hah, YoungSoo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2017-01-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201606566 |
Similar Items
-
Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
by: Dandan Chen, et al.
Published: (2023-06-01) -
A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau
by: Yang Gao, et al.
Published: (2023-11-01) -
Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
by: John David Eun, et al.
Published: (2022-07-01) -
DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
by: Sha Sha, et al.
Published: (2022-01-01) -
A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau
by: Zhouquan Jiang, et al.
Published: (2024-01-01)